Skip to main content

Table 1 Isolation density, resistance rates and incidence density of resistant isolates during the period 2008 – 2013

From: Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008–2013

 

Year

 
 

2008

2009

2010

2011

2012

2013

p-value*

Isolation density

       

( per 1000 patient-days)

Klebsiella pneumoniae

38.0

48.5

22.3

31.9

41.6

55.9

0.497 (0.005, from 2010 to 2013)

Acinetobacter baumannii

20.4

19.3

29.8

49.0

50.3

58.1

0.002

Resistance rates, %

       

(number of tested isolates)

3GC-resistant K. pneumoniae

88.7 (53)

69.4 (62)

41.9 (43)

67.2 (64)

87.0 (69)

81.6 (98)

0.806 (0.045 from 2010 to 2012)

ESBL-producing K. pneumoniae among 3GC-resistant K. pneumoniae

100

100

100

44.2

98.3

93.8

0.674

(39)

(42)

(18)

(43)

(59)

(80)

 

Carbapenem-resistant K. pneumoniae

0 (53)

9.7 (62)

2.3 (43)

37.5 (64)

63.8 (69)

59.2 (98)

0.010

Carbapenem resistant A. baumannii

87.5 (14)

95.0 (19)

96.2 (51)

98.9 (92)

93.2 (68)

96.6 (85)

0.021

Incidence density of resistant isolates ( per 1,000 patient-days)

       

3GC-resistant K. pneumoniae

25.9

25.1

8.9

19.3

32.8

35.5

0.367 (0.027 from 2010 to 13)

ESBL-producing K. pneumoniae among 3GC-resistant K. pneumoniae

21.5

24.6

8.9

8.5

31.7

33.2

0.436

Carbapenem-resistant K. pneumoniae

0

3.5

0.5

10.8

24.1

25.7

0.009

Carbapenem-resistant A. baumannii

7.7

11.1

25.3

41.3

37.2

37.7

0.014

  1. *Linear regression
  2. Significant values are indicated in bold font
  3. Abbreviation: 3GC third-generation cephalosporin, ESBL Extended-spectrum beta-lactamase